Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-040920
Filing Date
2005-07-19
Accepted
2005-07-19 10:58:27
Documents
1
Period of Report
2005-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - RESTRICTED STOCK GRANT rrd85665.html 4  
1 FORM 4 - RESTRICTED STOCK GRANT rrd85665.xml 4 3379
  Complete submission text file 0001181431-05-040920.txt   5072
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 SUTTON PLACE SOUTH, 19A NEW YORK NY 10022
Business Address 2124048910
Zecher Richard (Reporting) CIK: 0001303511 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 05960762